¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed leukocyte reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • alcohol flush reaction
    ¾ËÄÚ¿ÃÈ«Á¶¹ÝÀÀ
  • alkaline reaction
    ¾ËÄ®¸®¹ÝÀÀ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ
  • allograft reaction
    µ¿Á¾À̽ĹÝÀÀ
  • alternative reaction
    ±³´ë¹ÝÀÀ
  • anamnestic reaction
    ¸é¿ª±â¾ï¹ÝÀÀ
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, Ãʰú¹Î¹ÝÀÀ
  • anaphylactoid reaction
    À¯»ç¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, À¯»çÃʰú¹Î¹ÝÀÀ
  • bimolecular reaction
    À̺ÐÀÚ¹ÝÀÀ
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • biphasic reaction
    À̻󼺹ÝÀÀ
  • bisubstrate reaction
    µÎ±âÁú¹ÝÀÀ
  • biuret reaction
    ºä·¿¹ÝÀÀ
  • blanching reaction
    â¹é¹ÝÀÀ
  • blood transfusion reaction
    ¼öÇ÷¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • allograft reaction
    µ¿Á¾À̽ĹÝÀÀ
  • alternative reaction
    ±³´ë¹ÝÀÀ
  • anamnestic reaction
    ±â¿Õ¹ÝÀÀ
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, Ãʰú¹Î¹ÝÀÀ
  • anaphylactoid reaction
    À¯»ç¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, À¯»çÃʰú¹Î¹ÝÀÀ
  • anniversary reaction
    ±â³äÀϹÝÀÀ
  • anorectic reaction
    ½Ä¿å°áÇ̹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antiglobulin reaction
    Çױ۷κҸ°¹ÝÀÀ
  • antitryptic reaction
    Çׯ®¸³½Å¹ÝÀÀ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • arm tonus reaction
    À§ÆÈ±ÙÀ°±äÀå¹ÝÀÀ
  • Arthus reaction
    ¾Æ¸£Åõ½º¹ÝÀÀ
  • associated reaction
    ¿¬ÇÕ¹ÝÀÀ
  • autoimmune reaction
    ÀÚ°¡¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º ¹ÝÀÀ(Úãëë),Ãʰú¹Î¹ÝÀÀ
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã½º¾ç ¹ÝÀÀ, °ú¹ÎÁõ¼º ¹ÝÀÀ.
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã¾ç ¹ÝÀÀ, °ú¹ÎÁõ¼º ¹ÝÀÀ.
  • anniversary reaction
    ±â³äÀÏ ¹ÝÀÀ
  • anorectic reaction
    ½Ä¿å°áÇ̹ÝÀÀ
  • antigen-antibody reaction
    Ç׿ø-Ç×ü¹ÝÀÀ
  • antiglobulin reaction
    Çױ۷κҸ°¹ÝÀÀ.
  • antitryptic reaction
    Çׯ®¸³½Å ¹ÝÀÀ(~Úãëë).
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ(¡­Úãëë).
  • arm tonus reaction
    »óÁö±Ù ±äÀå ¹ÝÀÀ(ß¾ò¶ÐÉÑÌíåÚãëë).
  • arousal reaction=arousal response
    °¢¼º¹ÝÀÀ(ÊÆá¥Úãëë)
  • arthus reaction
    ¾Æ¸£¼ö½º ¹ÝÀÀ(¡­Úãëë)
  • fright reaction
    ³î¶÷¹ÝÀÀ(~Úãëë)
  • fuchsin number reaction
    Ç«½Å¼ö¹ÝÀÀ(¡­â¦Úãëë).
  • fuchsinophil reaction
    Ç«½Åģȭ¼º ¹ÝÀÀ(¡­Úãëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • mononuclear leukocyte
    ´ÜÇÙ¹éÇ÷±¸
  • motile leukocyte
    ¿îµ¿¼º ¹éÇ÷±¸(¡­àõÛÜúìϹ).
  • motile leukocyte
    ¿îµ¿¼º ¹éÇ÷±¸(ê¡ÔÑàõÛÜúìϹ)
  • motile leukocyte
    ¿îµ¿¼º ¹éÇ÷±¸(?ËÛËÑÌ´Ë´).
  • neutrophilic leukocyte
    È£Áß¼º ¹éÇ÷±¸(~ËÑÌ´Ë´).
  • neutrophilic leukocyte
    È£Áß¼º¹éÇ÷±¸
  • neutrophilic leukocyte
    È£Áß¼º ¹éÇ÷±¸(¡­ÛÜúìϹ)
  • neutrophilic metamyelocyte [juvenile neutrophilic leukocyte]
    È£Áß¼º´Ê°ñ¼ö¼¼Æ÷ (¾î¸°È£Áß¼º¹é
  • oxyphil leukocyte
    È£»ê±¸(Ì´Ë×Ë´).
  • oxyphil leukocyte
    È£»ê±¸(û¿ß«Ï¹).
  • polymorphonuclear leukocyte
    ´ÙÇÙ¹éÇ÷±¸
  • polymorphonuclear leukocyte
    ´ÙÇüÇÙ¹éÇ÷±¸(Òýû¡ú·ÛÜúìϹ), ´ÙÇüÇÙ±¸(Òýû¡ú·Ï¹)
  • polymorphonuclear leukocyte
    ´ÙÇüÇÙ(Òýû¡ú·)¹éÇ÷±¸, ´ÙÇüÇÙ±¸
  • segmented leukocyte
    ºÐ¿±ÇÙ±¸(ÝÂç¨ú·Ï¹).
  • segmented leukocyte
    ºÐ¿±ÇÙ±¸(ÝÂç¨ú·Ï¹)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • half-reaction
    ¹Ý¹ÝÀÀ(ÚâÚãëë)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • Hill reaction
    Èú ¹ÝÀÀ(Úãëë)
  • Hopkins-Cole reaction
    ȩŲ½º-ÄÝ ¹ÝÀÀ(Úãëë)
  • idling reaction
    À¯ÇÑ ¹ÝÀÀ(ë´ùØÚãëë)
  • immune reaction
    ¸é¿ª ¹ÝÀÀ(Øóæ¹Úãëë)
  • irreversible reaction
    ºñ°¡¿ª ¹ÝÀÀ(ުʦæ½Úãëë)
  • Liebermann-Burchard reaction
    ¸®¹ö¸¸-¹öÄ«µå¹ÝÀÀ(Úãëë)
  • light reaction
    ±¤¹ÝÀÀ(ÎÃÚãëë)
  • Lohmann reaction
    ·Î¸Ç ¹ÝÀÀ(Úãëë)
  • Millard reaction
    ¹Ð¶óµå ¹ÝÀÀ(Úãëë)
  • Mannich reaction
    ¸¸´ÏÈ÷ ¹ÝÀÀ(Úãëë)
  • Mehler reaction
    ¸á·¯ ¹ÝÀÀ(Úãëë)
  • Millon reaction
    ¹Ì¿ë ¹ÝÀÀ(Úãëë)
  • monomolecular reaction
    ´ÜºÐÀÚ¹ÝÀÀ(Ó¤ÝÂí­Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
WR Wassermann reaction; water retention; weakly reactive; weak response; whole response; wiping reactio...
DMH Daily Mixed Headache
DMLH Diffuse Mixed Lymphocytic Histiocytic
MC   1) Musculo-Cutaneous
  2) Mixed Cellularity
MCTD Mixed Connective Tissue Disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
LMIF Leukocyte migration inhibition factor
PMNE Polymorphonuclear leukocyte elastase
SLPI Secretory leukocyte proteinase inhibitor
SLA Swine Leukocyte Antigen
LC leukocyte common
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell mediated reaction
    ¼¼Æ÷ ¸Å°³¼º ¹ÝÀÀ
  • cessation reaction
    Á¤Áö ¹ÝÀÀ
  • chain initiation reaction
    ¿¬¼â °³½Ã ¹ÝÀÀ
  • conjugating reaction
    °áÇÕ ¹ÝÀÀ
  • conjunctival reaction
    °á¸· ¹ÝÀÀ
  • cross reaction
    ±³Â÷ ¹ÝÀÀ
    Ç׿ø Ç×ü ¹ÝÀÀÀÇ °¡Àå Å« Ư¡Àº ÀÌ ¹ÝÀÀÀÌ Æ¯ÀÌÀûÀ̶ó´Â °ÍÀε¥ ¶§·Î´Â ÀÌ ¿øÄ¢¿¡ ¸ÂÁö ¾Ê´Â ¹ÝÀÀÀ» º¸ÀÌ°Ô µÇ´Â ¼ö°¡ ÀÖ´Ù. ¿¹¸¦ µé¾î ¼ÒÀÇ Ç÷û ¾ËºÎ¹Î¿¡ ´ëÇÑ Ç×ü´Â ¾çÀÇ Ç÷û ¾ËºÎ¹Î°úµµ ¾î´À Á¤µµ ¹ÝÀÀÇϴµ¥ ÀÌ °°Àº ¹ÝÀÀÀ» ±³Â÷ ¹ÝÀÀÀ̶ó ÇÑ´Ù.
  • cutaneous reaction
    ÇǺΠ¹ÝÀÀ
  • Dakin-West`s reaction
    µ¥ÀÌŲ-¿þ½ºÆ® ¹ÝÀÀ
  • Dakin`s reaction
    µ¥ÀÌŲ ¹ÝÀÀ
  • delayed reaction
    Áö¿¬ ¹ÝÀÀ
  • depressive reaction
    ¿ì¿ï ¹ÝÀÀ
  • desmoid reaction
    Àδë¾ç ¹ÝÀÀ
  • donor reaction
    °øÇ÷ÀÚ ¹ÝÀÀ
  • emergency reaction
    ±ä±Þ ¹ÝÀÀ
  • endothermic reaction
    Èí¿­ ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
leukocyte bactericidal assay test A test of leukocytes to determine their ability to kill a culture of live bacteria.
(05 Mar 2000)
leukocyte common antigen Family of glycoproteins found on most leukocytes and absent from other cell types. These cell surface antigens can comprise up to 10% of the membrane proteins.
(05 Mar 2000)
leukocyte count A white blood cell (WBC) count.
(12 Dec 1998)
leukocyte cream <haematology> Thin yellow white layer of leucocytes on top of the mass of red cells when whole blood is centrifuged.
(18 Nov 1997)
leukocyte disorders Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.
(12 Dec 1998)
leukocyte elastase <enzyme> An enzyme that catalyses the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of ala and val, with greater specificity for ala.
Registry number: EC 3.4.21.37
(12 Dec 1998)
leukocyte esterase <enzyme> The presence of leukocyte esterase is indirect evidence for the presence of white blood cells in the urine. The standard urinalysis dip test allows for the quick determination of leukocyte esterase presence via a colour reaction on a urine test strip. A positive test indicates a urinary tract infection.
(27 Sep 1997)
leukocyte inclusions Discrete round or oval body's ranging in diameter from just visible to 2 um, which stain sky blue to gray blue with Romanowsky stains, found in neutrophils of patients with infections, burns, trauma, pregnancy, or cancer.
Synonym: Dohle inclusions, leukocyte inclusions.
(05 Mar 2000)
leukocyte interferon <cytokine> One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products.
It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukaemia.
A number of different subtypes exist that are elaborated by leukocytes in response to viral infection or stimulation with double-stranded RNA; IFN-alpha-2A and -2B are protein products made by recombinant DNA techniques and are used as antineoplastic agents.
See: interferon-alpha 2a, interferon-alpha 2b
Synonym: leukocyte interferon.
Pharmacological action: antineoplastic agent, antiviral agent.
(20 Sep 2002)
leukocyte migration-inhibitory factors Protein factor(s) released by sensitised lymphocytes (and possibly other cells) that inhibit the movement of leukocytes, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the leukocyte migration capillary tube technique (lmct) and the leukocyte migration agarose technique (lmat).
(12 Dec 1998)
leukocyte transfusion The transfer of leukocytes from a donor to a recipient or reinfusion to the donor.
(12 Dec 1998)
leukocyte tyrosine kinase receptor tyrosine kinase <enzyme> May be receptor for pre-b lymphocyte growth or differentiation factor; aa sequence given in first source
Registry number: EC 2.7.1.-
Synonym: ltk receptor tyrosine kinase, ltk receptor tk, ltk protein, leukocyte tyrosine kinase (ltk)
(26 Jun 1999)
lymphoma, mixed-cell Malignant lymphoma characterised by the presence of a mixed population of cells, with the smaller cells resembling lymphocytes and the larger ones histiocytes. It usually presents in a nodular (follicular) pattern, but may evolve into a diffuse pattern.
(12 Dec 1998)
lymphoma, mixed-cell, diffuse A heterogeneous group of intermediate-grade lymphomas of mixed cellular composition. Although they have not been extensively studied, it appears that they are predominantly B-cell diseases.
(12 Dec 1998)
lymphoma, mixed-cell, follicular A low-grade malignant lymphoma of follicular pattern in which there is no clear preponderance of one cell type (small or large) over another. The large cells, cleaved or noncleaved, are often 2-3 times larger in diameter than normal lymphocytes.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á